Methods of identifying anti-cancer agents and uses thereof
View Patent ↗The present invention provides methods of identifying and/or detecting anti-cancer agents. The present invention provides methods of identifying and/or detecting compounds that can activate PARP and/or induce necrosis. The present invention also provides for methods of treating cancer in an individual. The present invention also provides kits for identifying and/or detecting anti-cancer agents.
1. A method of identifying an agent that can activate PARP and induce cell death by necrosis comprising:
i) performing a test assay comprising:
a) contacting an immortalized cell that is deficient in Bax gene expression and Bak gene expression with a test compound,
b) measuring PARP activation, and
c) determining if the cell has undergone necrosis; and
ii) performing a positive control assay comprising:
a) contacting an immortalized cell that is deficient in Bax gene expression and Bak gene expression with a positive control compound,
b) measuring PARP activation, and
c) determining if the cell has undergone necrosis;
wherein the activation of PARP and induction of cell death by necrosis in said test assay indicates that the test compound can activate PARP and induce cell death by necrosis.
2. The method of claim 1 wherein said determining if the cell has undergone necrosis comprises measuring organelle swelling, intracellular vacuole formation, plasma membrane disintegration, and nuclear degradation without condensation.
3. The method of claim 1 , wherein said measuring PARP activation comprises measuring PAR polymers, NAD depletion, or ATP depletion.
4. The method of claim 1 , further comprising performing a negative control assay which comprises contacting an immortalized cell that is deficient in Bax gene expression and Bak gene expression with a negative control compound, measuring PARP activation, and determining if the cell has undergone necrosis.
5. A method of identifying an agent that can activate PARP and induce cell death by necrosis comprising performing a test assay comprising:
a) contacting an immortalized cell that is deficient in Bax gene expression and Bak gene expression with a test compound,
b) measuring PARP activation, and
c) determining if the cell has undergone necrosis;
wherein the activation of PARP and induction of cell death by necrosis in said test assay indicates that the test compound can activate PARP and induce cell death by necrosis.
6. The method of claim 5 wherein said determining if the cell has undergone necrosis comprises measuring organelle swelling, intracellular vacuole formation, plasma membrane disintegration, and nuclear degradation without condensation.
7. The method of claim 5 , wherein said measuring PARP activation comprises measuring PAR polymers, NAD depletion, or ATP depletion.
8. A method of identifying a compound which can induce cell death by necrosis in tumor cells in vitro comprising the steps of:
1) contacting a plurality of immortalized cells in vitro that are deficient in Bax gene expression and Bak gene expression with a test compound; and
2) determining if PARP is activated in said cells contacted with said test compound wherein the activation of PARP in said cells contacted with said test compound indicates that the test compound can induce cell death by necrosis in tumor cells in vitro.
9. The method of claim 8 , further comprises determining if the cell has undergone necrosis.
10. The method of claim 9 wherein said determining if the cell has undergone necrosis comprises measuring organelle swelling, intracellular vacuole formation, plasma membrane disintegration, and nuclear degradation without condensation.
11. The method of claim 8 , wherein said measuring PARP activation comprises measuring PAR polymers, NAD depletion, or ATP depletion.
12. The method of claim 8 , further comprising performing a negative control assay which comprises contacting an immortalized cell with a negative control compound and measuring PARP activation.
13. The method of claim 8 , further comprising performing a positive control assay which comprises contacting an immortalized cell with a positive control compound and measuring PARP activation.